Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Co Merck, Inc (2014) Belsomra [Package Insert, revised 2/2023]. Rahway, NJ, USA
2. Inc Eisai (2019) Dayvigo [Package Insert, revised 12/2023]. Nutley, NJ, USA
3. Hoyer D, Allen A, Jacobson LH (2020) Hypnotics with novel modes of action. Br J Clin Pharmacol 86:244–249. https://doi.org/10.1111/bcp.14180
4. Kishi T, Nomura I, Matsuda Y, Sakuma K, Okuya M, Ikuta T (2020) Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis. J Psychiatr Res 128:68–74. https://doi.org/10.1016/j.jpsychires.2020.05.025
5. Monkemeyer N, Thomas SV, Hilleman DE, Malesker MA (2022) Insomnia treatment update with a focus on orexin receptor antagonist. US Pharm 47:43–48